NLRP3 and Behcet disease: Our results presented the upregulation of IL1A expression and downregulation of NLRP3 in both groups of BD patients (BD-Lithium and BD-OD) compared to controls, thus suggesting that BD treatment impacts the NLRP3 inflammasome expression but may not affect the alternative way of IL1A expression.